- RecruitingPHASE1
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
This early-stage study is testing a new drug, INBRX-109, for people with advanced solid tumours, including certain types of Ewing sarcoma and bowel cancer. Researchers want to see if it's safe and how well it works, both alone and with standard treatments. This is for patients who haven't responded to previous therapies.
For: Ewing Sarcoma · Colorectal AdenocarcinomaUnited States · France · Italy - Active not recruitingPHASE2
Study of INBRX-109 in Conventional Chondrosarcoma
This study is testing a new medicine, INBRX-109, for people with a type of bone cancer called conventional chondrosarcoma that has spread or can't be removed by surgery. It compares the new medicine to a dummy treatment (placebo) to see if it's safe and effective.
For: Conventional ChondrosarcomaUnited States · Australia · France